The Val81 missense mutation of the melanocortin 3 receptor gene, but not the 1908C/T nucleotide polymorphism in lamin A/C gene, is associated with hyperleptinemia and hyperinsulinemia in obese Greek Caucasians

Journal of Endocrinological Investigation

Volumn 27, Issue 8, 2004, Pages 714-720

  Yiannakouris, N ^a   Melistas, L ^a   Kontogianni, M ^a   Heist, K ^b   Mantzoros, C S ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Genetic variation; Insulin; Lamin A C; Leptin; Melanocortin 3 receptor

Indexed keywords

INSULIN; LAMIN A; LAMIN C; LEPTIN; MELANOCORTIN 3 RECEPTOR; DNA; VALINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BODY COMPOSITION; BODY MASS; CAUCASIAN; CHROMOSOME 1Q; CHROMOSOME 20Q; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GREECE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN RESISTANCE; MISSENSE MUTATION; OBESITY; PHENOTYPE; PREDICTION; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT REDUCTION; BLOOD; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HYPERINSULINISM; MALE; PHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; AMINO ACID SUBSTITUTION; BODY COMPOSITION; BODY MASS INDEX; DNA; FEMALE; GENE FREQUENCY; GREECE; HUMANS; HYPERINSULINISM; INSULIN; LAMIN TYPE A; LEPTIN; MALE; MUTATION, MISSENSE; OBESITY; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 3; REGRESSION ANALYSIS; VALINE;

EID: 10244226787     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347511     Document Type: Article

References (23)

1. Chagnon YC, Rankinen T, Snyder EE, Weisnagel J, Perusse L, Bouchard C. The human obesity gene map: the 2002 update. Obes Res 2003, 11: 313-67.
2. Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet 1998, 18: 292-5.
3. Hegele RA, Anderson CM, Wang J, Jones DC, Cao H. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res 2000, 10: 652-8.
4. Lembertas AV, Perusse L, Chagnon YC, et al. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 1997, 100: 1240-7.
5. Lee JH, Reed DR, Li WD, et al. Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet 1999, 64: 196-209.
6. Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM. Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiol Genomics 2000, 3: 39-44.
7. Hegele RA, Huff MW, Young TK. Common genomic variation in LMNA modulates indexes of obesity in Inuit. J Clin Endocrinol Metab 2001, 86: 2747-51.
8. Weyer C, Wolford JK, Hanson RL, et al. Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21-q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab 2001, 72: 231-8.
9. Wolford JK, Hanson RL, Bogardus C, Prochazka M. Analysis of the lamin A/C gene as a candidate fortype II diabetes susceptibility in Pima Indians. Diabetologia 2001, 44: 779-82.
10. Chen AS, Marsh DJ, Trumbauer ME, et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000, 26: 97-102.
11. Butler AA, Kesterson RA, Khong K, et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141: 3518-21.
12. Li WD, Joo EJ, Furlong EB, et al. Melanocortin 3 receptor (MC3R) gene variants in extremely obese women. Int J Obes Relat Metab Disord 2000, 24: 206-10.
13. Hani EH, Dupont S, Durand E, et al. Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J Clin Endocrinol Metab 2001, 86: 2895-8.
14. Schalin-Jantti C, Valli-Jaakola K, Oksanen L, et al. Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord 2003, 27: 70-4.
15. Lee YS, Poh LK, Loke KY. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 2002, 87: 1423-6.
16. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant and diabetic subjects. J Clin Endocrinol Metab 2003, 88: 4848-56.
17. Deurenberg P, van der Kooy K, Leenen R, Weststrate JA, Seidell JC. Sex and age specific prediction formulas for estimating body composition from bioelectrical impedance: a cross-validation study. Int J Obes 1991, 15: 17-25.
18. Segal KR, van Loan M, Fitzgerald PI, Hodgdon JA, van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 1988, 47: 7-14.
19. Lin F, Worman HJ. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 1993, 268: 16321-6.
20. Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000, 9: 109-12.
21. Cummings DE, Schwartz MW. Melanocortins and body weight: a tale of two receptors. Nat Genet 2000, 26: 8-9.
22. Hinney A, Schmidt A, Nottebom K, et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999, 84: 1483-6.
23. Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003, 348: 1085-95.